These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 21103666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time.
    van Os GM, de Laat B, Kamphuisen PW, Meijers JC, de Groot PG.
    J Thromb Haemost; 2011 Aug; 9(8):1657-9. PubMed ID: 21668740
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M, Kopytek M, Natorska J, Undas A.
    Clin Chem Lab Med; 2019 Aug 27; 57(9):1374-1381. PubMed ID: 30763261
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
    Welzel D, Hull R, Fareed J.
    Int Angiol; 2011 Jun 27; 30(3):199-211. PubMed ID: 21617603
    [Abstract] [Full Text] [Related]

  • 11. Is there evidence for persistent or transient positive lupus anticoagulants according to the degree of prolongation of clotting tests?
    Devreese KM.
    Thromb Res; 2008 Jun 27; 122(4):576-9. PubMed ID: 18304615
    [No Abstract] [Full Text] [Related]

  • 12. Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study).
    Romualdi E, Donadini MP, Ageno W.
    Expert Rev Cardiovasc Ther; 2011 Jul 27; 9(7):841-4. PubMed ID: 21809964
    [Abstract] [Full Text] [Related]

  • 13. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
    Favaloro EJ, Mohammed S, Curnow J, Pasalic L.
    Pathology; 2019 Apr 27; 51(3):292-300. PubMed ID: 30665674
    [Abstract] [Full Text] [Related]

  • 14. Clinical management of rivaroxaban-treated patients.
    Palareti G, Ageno W, Ferrari A, Filippi A, Imberti D, Pengo V, Rubboli A, Toni D.
    Expert Opin Pharmacother; 2013 Apr 27; 14(5):655-67. PubMed ID: 23414291
    [Abstract] [Full Text] [Related]

  • 15. Determination of the anticoagulant effects of new oral anticoagulants: an unmet need.
    Harenberg J, Marx S, Erdle S, Krämer R.
    Expert Rev Hematol; 2012 Feb 27; 5(1):107-13. PubMed ID: 22272710
    [Abstract] [Full Text] [Related]

  • 16. Rivaroxaban for thromboprophylaxis.
    ten Cate H, Hamulyak K.
    N Engl J Med; 2008 Nov 13; 359(20):2174-5; author reply 2176. PubMed ID: 19009676
    [No Abstract] [Full Text] [Related]

  • 17. ISTH guidelines on lupus anticoagulant testing.
    Pengo V.
    Thromb Res; 2012 Oct 13; 130 Suppl 1():S76-7. PubMed ID: 23026672
    [No Abstract] [Full Text] [Related]

  • 18. Oral anticoagulation with rivaroxaban during pregnancy: a case report.
    Königsbrügge O, Langer M, Hayde M, Ay C, Pabinger I.
    Thromb Haemost; 2014 Dec 13; 112(6):1323-4. PubMed ID: 25055834
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Advances in venous thromboembolism].
    Qin L, Lu WX.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May 13; 36(5):372-4. PubMed ID: 24047815
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.